Literature DB >> 20858627

Which antibody and which cancer in which paraneoplastic syndromes?

Paul Gozzard1, Paul Maddison.   

Abstract

Paraneoplastic neurological syndromes can be associated with the presence of onconeural antibodies. These antibodies are the result of an immune response against a tumour that is ectopically expressing a neuronal antigen. The 'classical' onconeural antibodies (anti-Hu, Yo, Ma2, CRMP-5, amphiphysin and Ri) are directed against intracellular antigens and are strongly associated with underlying malignancy. By contrast, onconeural antibodies directed against cell surface antigens (eg, anti-NMDA, VGKC, AChR) have a weaker tumour association. This article gives a practical overview of the tumour associations, and the neurological associations, of the onconeural antibodies. There is also guidance on how to investigate occult malignancy in antibody positive cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858627     DOI: 10.1136/jnnp.2010.224105

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  11 in total

1.  A 60-year-old woman with chorea and weight loss.

Authors:  Amanda Vick; Ryan R Kraemer; Jason L Morris; Lisa L Willett; Robert M Centor; Carlos A Estrada; J Martin Rodriguez
Journal:  J Gen Intern Med       Date:  2011-12-06       Impact factor: 5.128

2.  Paraneoplastic limbic encephalitis with late-onset magnetic resonance imaging findings: A case report.

Authors:  Yoshiya Tsunoda; Takumi Kiwamoto; Shinsuke Homma; Yuuki Yabuuchi; Haruna Kitazawa; Toshihiro Shiozawa; Kensuke Nakazawa; Takashi Hosaka; Kazuhiro Ishii; Akiko Ishii; Akira Tamaoka; Nobuyuki Hizawa
Journal:  Mol Clin Oncol       Date:  2017-06-29

3.  Cancer and motor neuron disease-causal or coincidental? Two contrasting cases.

Authors:  John Goodfellow; George Gorrie; Veronica Leach; Sameer Patel; Graham Mackay
Journal:  Neurol Sci       Date:  2019-03-06       Impact factor: 3.307

4.  Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study.

Authors:  Paul Gozzard; Mark Woodhall; Caroline Chapman; Anjan Nibber; Patrick Waters; Angela Vincent; Bethan Lang; Paul Maddison
Journal:  Neurology       Date:  2015-06-24       Impact factor: 9.910

5.  Opsoclonus-myoclonus syndrome and exaggerated startle response associated with small-cell lung cancer.

Authors:  Elias S Sotirchos; E Ray Dorsey; Ik Lin Tan; David S Zee
Journal:  Mov Disord       Date:  2011-03-30       Impact factor: 10.338

6.  Synchronous Adie's syndrome and type 1 antineuronal nuclear antibody (anti-Hu)-related paraneoplastic neurological syndromes as predictors of complete response in limited-stage small-cell lung cancer: A case report.

Authors:  Katherina Bernadette Sreter; Blazenka Barisic; Marija Barisic Kutija; Suzana Kukulj; Miroslav Samarzija
Journal:  Mol Clin Oncol       Date:  2017-05-08

Review 7.  Paraneoplastic neurological syndromes.

Authors:  Francesc Graus; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2012-12       Impact factor: 5.710

8.  Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.

Authors:  Tao Cui; Monica Hurtig; Graciela Elgue; Su-Chen Li; Giulia Veronesi; Ahmed Essaghir; Jean-Baptiste Demoulin; Giuseppe Pelosi; Mohammad Alimohammadi; Kjell Öberg; Valeria Giandomenico
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

9.  Diagnostic Approach to a Patient With Paraneoplastic Neurological Syndrome.

Authors:  Ali Mahta; Namrata Vijayvergia; Tapan M Bhavsar; Lawrence D Ward
Journal:  World J Oncol       Date:  2012-10-28

10.  Rare association of anti-hu antibody positive paraneoplastic neurological syndrome and transitional cell bladder carcinoma.

Authors:  S Lukacs; N Szabo; S Woodhams
Journal:  Case Rep Urol       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.